CTOs on the Move

Oceana Therapeutics

www.oceanatherapeutics.com

 
Oceana Therapeutics is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Grin

Grin® is the first comprehensive teledental platform that connects patients with a real orthodontist from the convenience of their smart device. Delivering responsible care from orthodontic specialists in an easily accessible and cost-effective way, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.

PMSI

PMSI is the nation's leading single-source provider of prescription medications, medical equipment and in-home medical services for the workers' compensation, chronically ill and catastrophically inju.

Gladstone Institutes

Gladstone`s mission is to drive a new era of discovery in disease-oriented science and to mentor tomorrow`s leaders in an inspiring and diverse environment.

Biotics Research Corporation

Biotics Research Corporation is a Rosenberg, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.